MacuTherm Performance Study in Patients With iAMD
NCT: NCT07607496 · NOT_YET_RECRUITING
Brief Summary
The goal of this study is to demonstrate that photothermal therapy with the individually dosed treatment plan proposed by Macula Explorer delivered safely by Navilas® Laser System effectively improves the life of photoreceptors and reduces the progression of intermediate Age-related Macular Degeneration (iAMD) and preserves photoreceptors shown by Ellipsoid Zone Integrity (EZI). Participants will be randomized to either Treatment or Control Group. There will be 12 visits, monthly for the first 3 months, then quarterly until the end of the study after 2 years.
Frequently Asked Questions
What is MacuTherm Performance Study in Patients With iAMD?
MacuTherm Performance Study in Patients With iAMD is a clinical trial registered under NCT07607496. Current status: NOT_YET_RECRUITING.
What is the status of NCT07607496?
The current status of NCT07607496 (MacuTherm Performance Study in Patients With iAMD) is: NOT_YET_RECRUITING.
When did MacuTherm Performance Study in Patients With iAMD start?
MacuTherm Performance Study in Patients With iAMD started on 2026-05.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.